Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?

Michael D. Stutz(University of Melbourne), Marc Pellegrini(University of Melbourne)
Frontiers in Immunology
May 28, 2018
Cited by 15


Related Papers